These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 34239351)
1. Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma. Xu Y; Zuo W; Wang X; Zhang Q; Gan X; Tan N; Jia W; Liu J; Li Z; Zhou B; Zhao D; Xie Z; Tan Y; Zheng S; Liu C; Li H; Chen Z; Yang X; Huang Z Int J Biol Sci; 2021; 17(9):2223-2239. PubMed ID: 34239351 [TBL] [Abstract][Full Text] [Related]
2. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer. Zhuang J; Song Y; Ye Y; He S; Ma X; Zhang M; Ni J; Wang J; Xia W J Transl Med; 2019 Oct; 17(1):343. PubMed ID: 31619254 [TBL] [Abstract][Full Text] [Related]
3. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis. Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117 [TBL] [Abstract][Full Text] [Related]
4. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Wang H; Xu M; Zhang T; Pan J; Li C; Pan B; Zhou L; Huang Y; Gao C; He M; Xue Y; Ji X; Zhang X; Wang N; Zhou H; Wang Q; Li JZ Clin Transl Med; 2024 Oct; 14(10):e70045. PubMed ID: 39422696 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation. Guo J; Cheng X; Tian Y; Li B; Zhang X; Gao X; An Y Reprod Biol; 2021 Sep; 21(3):100534. PubMed ID: 34271243 [TBL] [Abstract][Full Text] [Related]
6. Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells. Zhang J; Shang L; Jiang W; Wu W Bioengineered; 2022 Mar; 13(3):7904-7918. PubMed ID: 35293266 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1 (pyrroline-5-carboxylate reductase 1). Li Z; Zhou X; Huang J; Xu Z; Xing C; Yang J; Zhou X Bioengineered; 2021 Dec; 12(2):9766-9778. PubMed ID: 34696668 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA Gong X; Zhu Z Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535 [No Abstract] [Full Text] [Related]
9. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF; Dai H; Ou Q; Zuo GQ; Liu CA Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417 [TBL] [Abstract][Full Text] [Related]
16. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X; Zhang P; Pan Y; Liu Y Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170 [TBL] [Abstract][Full Text] [Related]
18. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Jin J; Liu H; Jin M; Li W; Xu H; Wei F Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866 [TBL] [Abstract][Full Text] [Related]
19. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis. Sun T; Song Y; Yu H; Luo X Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4. Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]